New! Make Your CRM Smarter with Best-In-Class Intent Data

Learn More!
Biomason

Biomason

bioMASON, Inc. is a unique biomaterials startup whose technology provides a better solution for reducing the CO2 emissions generated by global masonry manufacturing. Cement is the second-most consumed substance on Earth - following water. bioMASON's biocement® building material is a biologically-derived, carbon neutral alternative cement. bioMASON's proprietary technology reduces CO2 emissions by using non-pathogenic microorganisms to grow structural biocement building material, providing an economically viable alternative to traditional processes and reducing global dependencies on non-renewable fuel sources and precious water resources. Biocement® building materials are only the beginning for this platform technology. bioMASON also is conducting research and development on a dust suppression application and a marine cement application for the U.S. Department of Defense.

Last updated on

About Biomason

Founded

2012

Estimated Revenue

$1M-$10M

Employees

51-250

Funding / Mkt. Cap

$95M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Durham

State

North Carolina

Country

United States

Tech Stack (76)

search